MedTrace Logo

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

NCT02543294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.

Conditions

  • Heart Failure
  • Cancer Treatment Induced Left Ventricular Dysfunction

Interventions

DEVICE

Echocardiograms

Participants undergo echocardiograms with contrast done at baseline and at months 2, 4, 6, 12, 18, and 30.

DEVICE

Electrocardiogram

Electrocardiogram performed at baseline.

BEHAVIORAL

Symptom Questionnaire

Symptom questionnaire completed at baseline and at months 1, 2, 4, 6, 12, 18, and 30.

BEHAVIORAL

Telephone Follow-Up

Telephone follow-up by study staff at months 3 and 5.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Anecita Fadol, PHD, MSN · M.D. Anderson Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-10
Primary Completion
2017-09-10
Completion
2017-09-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02543294 on ClinicalTrials.gov